Cytarabine (Ara-C)

Drug identity checked against registry records

Also recorded as Cytosar-U; Tarabine PFS; cytosine arabinoside (ara-C)

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AMLNCT07007312KURAPhase 3Recruiting2031-11Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.